Note: Ingredients listed on restricted chemical lists
EC/CAS
109-89-7
Name of the chemical
N,N-Diethylamine (Ethanamine, N-ethyl-)
Concentration
0.8-<2
EC/CAS
8000-48-4
Name of the chemical
Eucalyptus globulus oil (40)
Concentration
70-<71
General Information
Revision date
2021-11-24
Product name
VOLTAREN GEL 2%
Product Synonyms
CATAFLAMPRO XT EMULGEL 23,2 MG/G * PANADOL EMULGEL 12 HOURS * VOLTADOL
1.2.2. Uses advised against
No other uses are advised
Emergency telephone
VERISK 3E GLOBAL INCIDENT RESPONSE
Icons in SDS
Company Information
company name
GlaxoSmithKline Singapore Pharmaceuticals
e-mail address of the competent person responsible for the Safety Data Sheet
msds@gsk.com
GHS Information
Signal word
Danger
Section 2
Physical hazards
Not classified.
Health hazards
Skin corrosion/irritation Category 2 Serious eye damage/eye irritation Category 1 Specific target organ toxicity following Category 2 repeated exposure
Environmental hazards
Not classified.
Signal word
Danger
Hazard statements
Causes skin irritation. Causes serious eye damage. May cause damage to organs through prolonged or repeated exposure.
Prevention
Do not breathe dust/fume/gas/mist/vapours/spray. Wash hands thoroughly after handling. Wear eye protection/face protection. Wear protective gloves.
Response
IF ON SKIN Wash with plenty of water. IF IN EYES Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. Immediately call a POISON CENTRE/doctor/physician. If skin irritation occurs: Get medical advice/attention. Take off contaminated clothing and wash it before reuse.
Storage
Not available.
Disposal
Dispose of contents/container in accordance with local/regional/national/international regulations.
Other hazards which do not result in classification
This product will support combustion. Caution - Pharmaceutical agent. See section 11 of the SDS for additional information on health hazards.
Additional information
6.7 % of the mixture consists of component(s) of unknown acute oral toxicity. 11.02 % of the mixture consists of component(s) of unknown acute dermal toxicity. 10.07 % of the mixture consists of component(s) of unknown acute hazards to the aquatic environment. 10.07 % of the mixture consists of component(s) of unknown long-term hazards to the aquatic environment.
